These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16411303)

  • 21. The implantable cardiac defibrillator: is the glass half empty or half full?
    de Lissovoy G
    Med Care; 2007 May; 45(5):371-3. PubMed ID: 17446821
    [No Abstract]   [Full Text] [Related]  

  • 22. Eliminating out-of-pocket drug costs may improve outcomes after myocardial infarction--but at what cost to Medicare?
    Moran A; Goldman L
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):606-7. PubMed ID: 18695697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Implantable defibrillators. Good cost-effectiveness or supplementary expense to our hospitals?].
    Lévy S; Aliot E; Clémenty J; Kacet S; Coumel P
    Arch Mal Coeur Vaiss; 1999 Mar; 92(3):289-91. PubMed ID: 10221139
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
    Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
    J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medicare and cost-effectiveness analysis.
    Berger M; Honig P; Spatz I
    N Engl J Med; 2006 Jan; 354(2):207-9; author reply 207-9. PubMed ID: 16411304
    [No Abstract]   [Full Text] [Related]  

  • 26. Global cost-effectiveness of cataract surgery.
    Lansingh VC; Carter MJ; Martens M
    Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Zwanziger J; Hall WJ; Dick AW; Zhao H; Mushlin AI; Hahn RM; Wang H; Andrews ML; Mooney C; Wang H; Moss AJ
    J Am Coll Cardiol; 2006 Jun; 47(11):2310-8. PubMed ID: 16750701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.
    Cowie MR; Marshall D; Drummond M; Ferko N; Maschio M; Ekman M; de Roy L; Heidbuchel H; Verboven Y; Braunschweig F; Linde C; Boriani G
    Europace; 2009 Jun; 11(6):716-26. PubMed ID: 19359333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis.
    Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
    Cancer; 2008 Mar; 112(5):1058-65. PubMed ID: 18186497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of aortic valve replacement in the elderly: an introductory study.
    Wu Y; Jin R; Gao G; Grunkemeier GL; Starr A
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):608-13. PubMed ID: 17320552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of using US-Valued EQ-5D health states for comparative effectiveness and cost-effectiveness studies in US populations.
    Miller W
    Med Decis Making; 2007; 27(3):229-30. PubMed ID: 17545493
    [No Abstract]   [Full Text] [Related]  

  • 32. The high cost of implantable defibrillators.
    Hlatky MA; Mark DB
    Eur Heart J; 2007 Feb; 28(4):388-91. PubMed ID: 17032689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medicare and cost-effectiveness analysis.
    Schulman KA
    N Engl J Med; 2006 Jan; 354(2):207-9; author reply 207-9. PubMed ID: 16407521
    [No Abstract]   [Full Text] [Related]  

  • 34. Approach to cost-effectiveness assessment in the MADIT trial. Multicenter Automatic Defibrillator Implantation Trial.
    Mushlin AI; Zwanziger J; Gajary E; Andrews M; Marron R
    Am J Cardiol; 1997 Sep; 80(5B):33F-41F. PubMed ID: 9291448
    [No Abstract]   [Full Text] [Related]  

  • 35. Is cost-effectiveness analysis unfair?
    Russell LB
    Med Decis Making; 2004; 24(2):232-4. PubMed ID: 15090108
    [No Abstract]   [Full Text] [Related]  

  • 36. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
    Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
    Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Money matters: how cost-effectiveness studies are done.
    Zielinski SL
    J Natl Cancer Inst; 2004 Oct; 96(19):1411. PubMed ID: 15467024
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost-effectiveness of lay responder defibrillation for out-of-hospital cardiac arrest.
    Nichol G; Huszti E; Birnbaum A; Mahoney B; Weisfeldt M; Travers A; Christenson J; Kuntz K;
    Ann Emerg Med; 2009 Aug; 54(2):226-35.e1-2. PubMed ID: 19321228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of quality-adjusted life-years in cost-effectiveness studies.
    Sculpher M
    Allergy; 2006 May; 61(5):527-30. PubMed ID: 16629779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.